Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register PHARMAC for InfoPages here.
PHARMAC - Latest News [Page 31]
NZ in top rung of nations funding new cancer drug
Monday, 4 November 2002, 1:01 pm | PHARMAC
New Zealand will become one of the first countries in the world to fund imatinib mesylate (Glivec) as a first line treatment for chronic myeloid leukaemia, should the new therapy be approved for this use by the Ministry of Health. More >>
NZMJ paper shows wide regional variations
Friday, 11 October 2002, 9:50 am | PHARMAC
A new study published in this week’s New Zealand Medical Journal shows wide regional variations in the uptake of the cholesterol-lowering statin drugs. More >>
PHARMAC, Novartis reach agreement on Glivec
Wednesday, 2 October 2002, 10:39 am | PHARMAC
PHARMAC has reached a provisional agreement with Novartis to fund the cancer drug Glivec for a wide group of New Zealanders. More >>
Funky mini-CD to aid prescribing
Thursday, 26 September 2002, 12:06 am | PHARMAC
Prescribers will have easier access to information on subsidised medicines in the form of a new electronic version of the Pharmaceutical Schedule, which has been launched by PHARMAC. More >>
PHARMAC to review HRT treatments
Monday, 23 September 2002, 10:08 am | PHARMAC
The move follows international concern about the long-term use of hormone replacement therapy (HRT) being raised by a study published in the Journal of the American Medical Association (JAMA). More >>
Strategy to improve Maori use of pharmaceuticals
Tuesday, 10 September 2002, 5:11 pm | PHARMAC
Improving Maori health through the use of pharmaceuticals and increasing PHARMAC’s responsiveness to Maori health needs are two of the key areas addressed in PHARMAC’s Maori Responsiveness Strategy. More >>
Working towards Glivec funding solution
Monday, 29 July 2002, 2:27 pm | PHARMAC
PHARMAC is to continue to seek an agreement with pharmaceutical supplier Novartis that would enable Glivec to be funded for people with chronic myeloid leukaemia (CML). More >>
Pharmac Thinks Small In Latest Tender List
Monday, 24 June 2002, 9:30 am | PHARMAC
Preserving subsidised access to a number of very small volume products and the return of innovator drugs to full funding on the Pharmaceutical Schedule are features of the latest list of sole supply contracts awarded under the PHARMAC tender. More >>
Pharmac To Consult On Glivec Access Criteria
Friday, 31 May 2002, 9:47 am | PHARMAC
PHARMAC is to begin consultation on access criteria for the chronic myeloid leukaemia (CML) drug Glivec (imatinib mesylate). More >>
New Process To Ensure Fair Access To Cancer Drugs
Thursday, 9 May 2002, 3:36 pm | PHARMAC
Cancer patients throughout New Zealand will have equal access to cancer drugs under a new assessment process run by PHARMAC. More >>
Discussions On Glivec Make Further Progress
Wednesday, 1 May 2002, 5:11 pm | PHARMAC
PHARMAC and Novartis have agreed on some key areas as they progress their discussions on funding the chronic myeloid leukaemia drug Glivec (imatinib mesylate). More >>
New Campaign Tackles Killer Head-On
Wednesday, 17 April 2002, 10:09 am | PHARMAC
The biggest single killer of New Zealanders is being tackled by a new public information campaign launched at Parliament today. More >>
Pharmac To Fund New Arthritis Drug
Monday, 15 April 2002, 10:08 am | PHARMAC
Pharmac has reached an agreement with Aventis Pharma Ltd to fully fund the arthritis drug leflunomide. More >>
PHARMAC Ready To Recommend Funding For Glivec
Wednesday, 10 April 2002, 9:36 am | PHARMAC
PHARMAC would like to subsidise the chronic myeloid leukaemia drug Glivec, but the price needs to be lower, says PHARMAC Chief Executive Wayne McNee. More >>
Children With Asthma Get More Help To Breathe Easy
Tuesday, 19 March 2002, 9:27 am | PHARMAC
Children with asthma having difficulty using existing puffer-style inhalers have been given good news, following PHARMAC announcing it will fully fund an asthma device that is easier for them to use. More >>
PHARMAC Delivers Good News To People With Glaucoma
Tuesday, 12 March 2002, 2:54 pm | PHARMAC
PHARMAC is providing more fully-funded treatments for the debilitating eye condition glaucoma, and widening access to existing treatments. More >>
Easier Access For Ranitidine Liquid – PHARMAC
Wednesday, 20 February 2002, 3:18 pm | PHARMAC
PHARMAC is making it easier for patients to access the liquid form of the stomach ulcer and heartburn drug ranitidine. More >>
Potential Pitfall Of Drug Company Free Supply
Wednesday, 9 January 2002, 10:45 am | PHARMAC
PHARMAC is reminding drug companies that it is unethical to pull the plug on providing patients with drugs free of charge, once the patients have started on the treatment. More >>
PHARMAC cuts taxpayer bill by almost $500 million
Wednesday, 10 October 2001, 2:00 pm | PHARMAC
Figures just released by PHARMAC show that the current drug bill would have cost the taxpayer almost half a billion dollars more without its intervention. More >>
PHARMAC Frees Up Access To Hormone Treatment
Monday, 20 August 2001, 4:21 pm | PHARMAC
PHARMAC has announced that it is freeing up access to a hormone treatment that is used for oral contraception and a number of conditions including severe acne, polycystic ovary syndrome and abnormal hair growth. More >>
